Table 5.

Treatment of Manifestations in Individuals with TNXB-Related Classical-Like Ehlers-Danlos Syndrome

Manifestation/ConcernTreatmentConsiderations/Other
Hypotonia / Gross
motor delay
Standard treatment by PTNon-weight-bearing muscular exercise, such as swimming, is useful to promote muscular development & coordination.
Joint laxity/
dislocations
For recommendations on treatment, see Hypermobile EDS.Surgical stabilization of joints may lead to minimal or only temporary improvement.
Joint pain
  • Non-weight-bearing exercise
  • For recommendations on pain medication, see Hypermobile EDS.
  • Careful selection of analgesic medication is recommended in light of ↑ risks of diverticulitis & diverticular bleeding in users of aspirin or NSAIDs.
  • Consider referral to rheumatologist &/or pain mgmt specialist or clinic.
  • Avoid use of opioid medication for chronic pain; it does not relieve pain long term & can → addiction.
  • Long-term chronic pain may → need for mental health services.
Subjective muscle
weakness
Standard eval & treatment per neurologist
Vessel/organ rupture Prompt assessment & mgmt in tertiary care center
Cardiac/valvular
abnormalities
Standard treatment per cardiologist
Easy bruising Ascorbic acid (vitamin C) may ↓ easy bruising but has no effect on primary findings of skin hyperextensibility or joint hypermobility.In general, a dose of 2 g/day is recommended for adults, w/proportionally ↓ doses for children; however, there is no limitation.
DDAVP® may be useful to normalize bleeding time.May be beneficial in case of bruising or epistaxis, or before procedures such as dental extractions
See also Classic EDS.

EDS = Ehlers-Danlos syndrome; NSAID = nonsteroidal anti-inflammatory drug

From: TNXB-Related Classical-Like Ehlers-Danlos Syndrome

Cover of GeneReviews®
GeneReviews® [Internet].
Adam MP, Feldman J, Mirzaa GM, et al., editors.
Seattle (WA): University of Washington, Seattle; 1993-2024.
Copyright © 1993-2024, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.

GeneReviews® chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (http://www.genereviews.org/) and copyright (© 1993-2024 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the GeneReviews® Copyright Notice and Usage Disclaimer. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.

For more information, see the GeneReviews® Copyright Notice and Usage Disclaimer.

For questions regarding permissions or whether a specified use is allowed, contact: ude.wu@tssamda.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.